Study Compares Mass Spectrometry Methods for Lung Disease Protein Analysis
A new preprint study compared two mass spectrometry acquisition strategies—data-independent acquisition (DIA MS) and data-dependent acquisition (DDA MS)—for profiling proteins in lung fluid and cells from patients with beryllium-related lung disease. While DDA MS identified more total proteins in some compartments, DIA MS achieved markedly superior quantitative completeness, quantifying approximately 99% of detected proteins across all samples in BAL cells versus about 63% for DDA MS. The findings suggest DIA MS is better suited for biomarker discovery and large-scale quantitative lung proteomics.
Researchers used beryllium-related granulomatous lung disease as a model system to benchmark DDA MS against DIA MS in analyzing bronchoalveolar lavage (BAL) cells and BAL fluid (BALF) from beryllium-sensitized individuals. In BAL cells, DDA MS identified more total proteins (5,640 vs. 5,227), but DIA MS quantified 5,178 proteins (~99%) consistently across all samples, compared to only 3,539 (~63%) for DDA MS. DIA MS also uniquely quantified 1,781 lower-abundance proteins not captured by DDA MS. Both methods detected pathways linked to granulomatous inflammation—including Toll-like receptor and C-type lectin receptor signaling—but DIA MS additionally resolved complement cascade, coagulation system, and JAK/IL-6 cytokine signaling pathways. In BALF, DDA MS identified more proteins overall (2,069 vs. 1,742), yet DIA MS again showed greater quantitative completeness (1,695 vs. 1,050 proteins quantified across all samples). The authors conclude that DIA MS offers a more robust and sensitive platform for discovering disease-relevant protein signatures in lung biofluid compartments.
What's missing
The study is a preprint and has not yet undergone peer review. Key limitations include the relatively small and potentially homogeneous patient cohort (beryllium-sensitized individuals only), which may limit generalizability to other granulomatous or lung diseases. The study does not report clinical validation of the candidate biomarkers identified, nor does it address the cost, throughput, or accessibility trade-offs between DIA and DDA workflows in routine clinical settings. The degree to which DIA MS performance advantages hold across different instrument platforms or sample preparation protocols remains an open question.
What different sources said
- bioRxivCenter
Comparative Evaluation of DDA and DIA Based Proteomic Workflows in Beryllium Related Lung Disease
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.